Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Study:

n/a

Rationale:

n/a

Purpose:

The purpose of this study is to prospectively evaluate the incidence of hemodynamic compromise and to obtain long-term survival data on patients with the AMPLATZER Septal Occluder

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Atrial Septal Defect Device: AMPLATZER Septal Occluder N/A

Verified by AGA Medical Corporation March, 2013

Sponsored by: AGA Medical Corporation
Information provided by: AGA Medical Corporation
ClinicalTrials.gov identifier: NCT00650936

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

The Children`s Hospital at Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site